A5062Introduced in the General Assembly
Requires health insurance and Medicaid coverage for testing and treatments to slow progression of Alzheimer's disease and related disorders.
Introduced by Carol Murphy, District 7
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
Requires health insurance and Medicaid coverage for testing and treatments to slow progression of Alzheimer's disease and related disorders.
Where it stands
Received in the Senate, Referred to Senate Commerce Committee
September 28, 2026
How did lawmakers vote?
General AssemblyStage: Assembly Floor: Third Reading - Final Passage · June 30, 2026
78
Yes
0
No
2
Absent or Not Voting
80 assemblymembers recorded in this General Assembly vote. Colors show vote categories only, not whether a vote was good or bad.
See how each assemblymember voted
| Assemblymember | District | Vote |
|---|---|---|
| Erik Simonsen | 1 | Yes |
| Antwan McClellan | 1 | Yes |
| Don Guardian | 2 | Yes |
| Maureen Rowan | 2 | Yes |
| David Bailey | 3 | Yes |
| Heather Simmons | 3 | Yes |
| Dan Hutchison | 4 | Yes |
| Cody Miller | 4 | Yes |
| William Spearman | 5 | Yes |
| William Moen | 5 | Yes |
Bill history
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Transferred to Assembly Appropriations Committee
Reported out of Assembly Committee, 2nd Reading
Passed by the Assembly (78-0-1)
Received in the Senate, Referred to Senate Commerce Committee
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.